Skip to content
TrustList
H.I.G. BioVentures logo
Venture capital firm

H.I.G. BioVentures

Healthcare investment team backing companies across pharma, biotech, devices and diagnostics

H.I.G. BioVentures cover

TrustList summary

H.I.G. BioVentures is the healthcare investing arm shown on the H.I.G. BioHealth Partners site. It puts money into a broad range of healthcare companies across sectors and stages, especially those developing products for serious unmet medical needs.

What H.I.G. BioVentures does

  • Healthcare investing: backing firms at different stages of development.
  • Sector expertise: investors who have worked in large drug companies, small biotechs, device makers, diagnostics, laboratory science, clinical trials and licensing of university research.
  • Portfolio news: updates on companies such as Nevakar, Leiters, Exagen, BIOVECTRA, Zerigo Health and Endpoint Health.

Clients

Healthcare companies creating new products, from injectables and outsourced pharmacy to digital health and precision immunology.

Key facts

  • Focus: healthcare, life sciences
  • Group: H.I.G. BioHealth Partners

Summary written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

H.I.G. BioVentures is ranked on 9 TrustList rankings: #14 on 1, #16 on 1, #18 on 1, #25 on 1, #34 on 1, #41 on 1, #43 on 2 and #45 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. H.I.G. BioVentures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 9 rankings

On 2 of these it sits behind Greenhill Capital Partners, ahead of Harbert Growth Partners.

  • #14of 28
    Dubai

    It is the only one of the 28 here listing biotech and medical.

    Of the 28 here, 8 also cover partners and 4 also cover internet; 15 also work in London and 14 also work in New York City.

    Behind FS Investments, ahead of Hudson Bay Capital.

  • #16of 27
    Milan

    It is the only one of the 27 here listing partnership and one of 2 here listing partners.

    Of the 27 here, 4 also cover banking and 3 also cover private equity; 9 also work in Paris and 7 also work in Hong Kong.

    Behind Fondo Italiano di Investimento, ahead of Keen Venture Partners.

  • #18of 32
    Madrid

    It is the only one of the 32 here listing medical and one of 2 here listing biotech.

    Of the 32 here, 3 also cover seed stage and 3 also cover series a; 8 also work in Sydney and 7 also work in San Francisco.

  • #25of 38
    Miami

    It is the only one of the 38 here listing medical and one of 3 here listing biotech.

    Of the 38 here, 6 also cover series and 5 also cover construction; 8 also work in Chicago and 6 also work in Los Angeles.

    Behind Glade Brook Capital Partners, ahead of H20 Capital Innovation.

  • #34of 64
    Los angeles

    It is one of 3 here listing medical and one of 4 here listing biotech.

    Of the top 58 here, 9 also cover growth stage and 5 also cover partnership; 7 also work in Silicon Valley and 6 also work in Washington, Dc.

    Behind Gunderson Dettmer, ahead of Hiro Capital.

  • #41of 79
    Biotech investors

    It is one of 6 here listing partnership and one of 10 here listing medical.

    Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston.

    Behind Google Ventures, ahead of Heuristic Capital Partners.

  • #43of 83
    Paris

    It is one of 2 here listing medical and one of 3 here listing biotech.

    Of the top 65 here, 7 also cover environmental and 6 also cover energy; 10 also work in Munich and 9 also work in Madrid.

  • #43of 69
    Hong kong

    It is one of 3 here listing partnership and one of 4 here listing biotech.

    Of the top 59 here, 6 also cover fintech; 21 also work in Shanghai and 15 also work in Tokyo.

    Behind GT Healthcare Capital Partners, ahead of Hong Leong Financial Group.

  • #45of 87
    Chicago

    It is one of 2 here listing medical and one of 4 here listing biotech.

    Behind Greenhill Capital Partners, ahead of Harvard Business School Angels Chicago.

As of 2026-10-31. Organic ranks only; sponsored placements are never ranks. How TrustList ranks

Ask TrustList to introduce you to H.I.G. BioVentures

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of H.I.G. BioVentures

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about H.I.G. BioVentures.

H.I.G. BioVentures alternatives

Similar listings buyers compare against this one.

Private investment firm with offices in New York and London backing healthcare technology and other companies

New York boutique venture firm investing in growth-stage technology companies across several sectors

A venture capital firm investing only in public blockchain infrastructure and application companies

New York strategic consulting, venture equity and business development firm advising companies, investors and entrepreneurs

Indonesian conglomerate-backed fund investing in venture capital firms and founders across Southeast Asia

Venture arm of Alchemy investing in early-stage teams building web3 and onchain products